Investing Profile

Stephen Knight

InvestorVC

President and Managing Partner at F-Prime Capital Partners

fprimecapital.com/people/step...Cambridge, Massachusetts

Your Intro Paths to Stephen Knight

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Stephen Knight on

Current Investing Position

F-Prime Capital Partners Managing Partner

Investment Range

$100K - $10.0M

Sweet Spot

$5.0M

Investments On Record

Stephen Knight is on these Sector & Stage Rankings

Pharmaceuticals (Series A)BioTech (Series A)Health & Hospital Services (Series A)Health IT (Series A)Pharmaceuticals (Series B)BioTech (Series B)Health & Hospital Services (Series B)Health IT (Series B)Boston / New England

Stephen Knight's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Quantum Circuits	Series BMay 2024$60M	$78M
Co-investors: Bill Coughran (Sequoia Capital), Brendan Dickinson (Canaan Partners), Corey Ritter (ARCH Venture Partners), Eugene Chiu (In-Q-Tel)
Genomics	Series CJan 2024$45M Series UnknownMar 2021$30M Series BDec 2018$9M	$84M
Co-investors: Jim Tananbaum (Foresite Capital)
Paradigm	Series AJan 2023$200M	$240M
Co-investors: Elena Viboch (General Catalyst), Ramnik Arora (FTX Ventures), Hemant Taneja (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Jay Markowitz (ARCH Venture Partners), Arash Ferdowsi, Scott Belsky, Eoghan McCabe, Alaa Halawa
Ensoma	Series BJan 2023$85M Series AFeb 2021$70M	$210M
Co-investors: Kush Parmar (5am Ventures), Kouki Harasaki (Bioluminescence Ventures), Mark Chin (Arix Bioscience)
Aerium Therapeutics	Series AMar 2022
Co-investors: Michael Powell (Omega Funds), Vincent Ossipow (Omega Funds)
Leyden Labs	Series BJan 2022$140M Series AMar 2021$47M	$260M
Co-investors: David Schenkein (GV (Google Ventures)), Nisa Leung (Qiming Venture Partners), Brook Byers (Kleiner Perkins)
Prime Medicine	Series BJul 2021$200M Series AOct 2019$120M	$320M
Co-investors: David Schenkein (GV (Google Ventures)), Stephen Francis (Arrive), Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive)
Atalanta Therapeutics	Series AJan 2021$110M	$110M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners)